NHP iPSC-Derived vCMs for in vitro Safety and Toxicity Screening
In Vitro Safety Profiling of ADCs Using an iPSC-Derived Human Tissue Screen
Automated Generation of 3D iPSC-Based Cardiac Microtissues for High-Throughput ...
A Human iPSC-Based Platform for Functional Toxicity Screening of CNS-Targeted RNA ...
Fact Sheet: Ncyte® Plate-Ready vCardiomyocytes
User guide: Ncyte® Plate-ready vCardiomyocytes
User guide: NHP-C vCardiomyocytes
Fact Sheet: Ncyte® NHP-C vCardiomyocytes
Development of robust iPSC-based α-Synuclein, Tau and TDP-43 aggregation models for ...
A human scalable platform for high-throughput screening of drug candidates targeting ...
.png)
Designing cardiac assays for multi-year discovery and safety pipelines
Beyond binding – iPSC-based functional safety screening for oncology modalities
Advancing Gene Therapy Potency Testing with iPSC-Based Systems
Revolutionizing Cardiac Safety Assessment with NHP Cardiomyocytes
A Reduction in Animal Testing Stems From Ncardia
See How Ncardia Is Supporting the Shift From Animal Models With iPSC Technology
Advancing High-Throughput Cardiac Screening With Physiologically Relevant 3D ...
.png)
Breaking New Ground in ALS Research
Ready-to-use iPSC-based assay to screen ALS therapeutics
Webinar: Human Hematopoietic Stem Cell Manufacturing from iPSCs
-1.png)
Press release: Ncardia and Cellistic appoint Jason Conner as new CEO
Industry Insights: Early Safety and Human-Relevant Models Gain Strategic Weight
Ncardia and LUMC Develop Automated Human Cardiac Microtissue Platform
Scaling Human Biology: Mariana Argenziano's Impact on iPSC Manufacturing
.svg)
Human-Relevant Discovery Begins With the Model: A Conversation With Shushant Jain
.png)
Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne ...
Driving Predictive Science Forward: Inside the Shift Toward Human-Relevant Drug ...
Press release: Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate ...
The FDA Is Moving Past Animal Testing. Here’s How Ncardia Helps Make It Happen
Press release: Ncardia launches Ncyte® Microglia